Apogee Therapeutics APGE
NASDAQ APGE
$135.07 -0.01 (-0.01%)
At close: Sep 2, 2026 · 4:00 PM EDT

Apogee Therapeutics (APGE) Property, Plant & Equipment (Net) (2023 - 2026)

Analysis

Apogee Therapeutics (APGE) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 1.96 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 34.61 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 107.22 Mn
10 Apogee Therapeutics 10.18 Bn 9.20 Bn - 4.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.82 Mn
Mar 31, 2026 5.28 Mn
Dec 31, 2025 5.69 Mn
Sep 30, 2025 6.03 Mn
Jun 30, 2025 6.44 Mn
Mar 31, 2025 5.70 Mn
Dec 31, 2024 1.96 Mn
Sep 30, 2024 1.42 Mn
Jun 30, 2024 714,000.00
Mar 31, 2024 699,000.00
Dec 31, 2023 377,000.00